Cerity Partners
RVMD icon

Cerity Partners’s Revolution Medicines RVMD Stock Holding History

Cerity Partners’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7M Buy
37,364
+19,701
+112% +$2.88M 0.01% 945
2026
Q1 		$1.72M Buy
17,663
+3,675
+26% +$371K ﹤0.01% 1569
2025
Q4 		$1.11M Sell
13,988
-715
-5% -$46.9K ﹤0.01% 1664
2025
Q3 		$687K Buy
14,703
+1,101
+8% +$43.1K ﹤0.01% 1784
2025
Q2 		$500K Buy
13,602
+4,533
+50% +$174K ﹤0.01% 1852
2025
Q1 		$321K Buy
9,069
+3,370
+59% +$137K ﹤0.01% 1991
2024
Q4 		$250K Buy
+5,699
New +$288K ﹤0.01% 2122

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Cerity Partners's RVMD Position: Q2 2026 in Review

Cerity Partners increased its Revolution Medicines (RVMD) stake by 112% in Q2 2026, buying an estimated $2.88M and bringing the position to 37,364 shares worth $7M. The position accounts for 0.01% of the portfolio, ranked #945.

Cerity Partners first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Cerity Partners held 37,364 shares of Revolution Medicines worth $7M as of Q2 2026.
  • Cerity Partners bought 19,701 Revolution Medicines shares in Q2 2026, an estimated $2.88M.
  • Revolution Medicines made up 0.01% of Cerity Partners's portfolio in Q2 2026, its #945 holding.
  • Cerity Partners first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.